- Home
- CREV vs ALBT Comparison
CREV vs ALBT Comparison
Compare CREV & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CREV
- ALBT
- Stock Information
- Founded
- CREV 2007
- ALBT 2014
- Country
- CREV Ireland
- ALBT United States
- Employees
- CREV N/A
- ALBT N/A
- Industry
- CREV
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CREV
- ALBT Health Care
- Exchange
- CREV Nasdaq
- ALBT Nasdaq
- Market Cap
- CREV 6.0M
- ALBT 5.7M
- IPO Year
- CREV N/A
- ALBT N/A
- Fundamental
- Price
- CREV $4.90
- ALBT $2.57
- Analyst Decision
- CREV
- ALBT
- Analyst Count
- CREV 0
- ALBT 0
- Target Price
- CREV N/A
- ALBT N/A
- AVG Volume (30 Days)
- CREV 691.3K
- ALBT 104.6K
- Earning Date
- CREV 05-14-2025
- ALBT 08-18-2025
- Dividend Yield
- CREV N/A
- ALBT N/A
- EPS Growth
- CREV N/A
- ALBT N/A
- EPS
- CREV N/A
- ALBT N/A
- Revenue
- CREV $39,261,077.00
- ALBT $807,235.00
- Revenue This Year
- CREV $40.76
- ALBT N/A
- Revenue Next Year
- CREV $86.18
- ALBT N/A
- P/E Ratio
- CREV N/A
- ALBT N/A
- Revenue Growth
- CREV 41.52
- ALBT N/A
- 52 Week Low
- CREV $2.00
- ALBT $2.11
- 52 Week High
- CREV $14.19
- ALBT $12.60
- Technical
- Relative Strength Index (RSI)
- CREV 70.80
- ALBT 37.26
- Support Level
- CREV $2.51
- ALBT $2.52
- Resistance Level
- CREV $4.26
- ALBT $2.74
- Average True Range (ATR)
- CREV 0.74
- ALBT 0.28
- MACD
- CREV 0.27
- ALBT -0.01
- Stochastic Oscillator
- CREV 83.07
- ALBT 5.15
About CREV Carbon Revolution Public Limited
Carbon Revolution PLC is an Australian-based technology company manufacturing carbon fiber wheels. It is an OEM supplier and a world-wide manufacturer of lightweight technology carbon fibre wheels to the automotive industry. The Company supplies wheels to OEMs across the globe for luxury and high-performance vehicles and SUVs, and is developing wheels for electric vehicles under contract for its OEM customers. The company generates maximum revenue Internationally.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.